# OnCo record paper-apt-trial-lancet-oncol-2023-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-apt-trial-lancet-oncol-2023-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-apt-trial-lancet-oncol-2023-update" ;
  schema:name "Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial"@en ;
  schema:description "Later report from the trial registered as NCT00542451, in The Lancet Oncology (2023); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-apt-trial-lancet-oncol-2023-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(23)00051-7>, <https://pubmed.ncbi.nlm.nih.gov/36858723/>, <https://europepmc.org/article/MED/36858723>, <https://clinicaltrials.gov/study/NCT00542451> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(23)00051-7> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Tolaney SM, Tarantino P, Graham N, et al." ;
  onco:trials <https://onco.cc/trials/apt-trial/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .